跳至主要内容
临床试验/NCT07623720
NCT07623720已完成不适用

Four Years Extended Follow-Up on CorVision® Bioengineered Corneal Microlens: Safety and Efficacy

Gemini Eye Clinic1 个研究点 分布在 1 个国家目标入组 95 人开始时间: 2025年6月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
95
试验地点
1
主要终点
Uncorrected Near Visual Acuity of 0.3 logMAR or better

研究概览

简要总结

The objective of the study is to assess the long-term safety and effectiveness of the CorVision® microlens implanted in presbyopic patients for the management of management of presbyopia and near vision impairment. Approximately 100 patients in the Czech Republic will participate in this study. The study was reviewed and approved by an independent research ethics committee and also by the State Institute for Drug Control (SÚKL). The study will consist of a single visit during which standard, non-invasive, and painless examinations will be performed. This visit will correspond to the 4-year follow-up visit of the original clinical trial.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •Subjects must have undergone implantation of CorVision microlens under study protocol CMG-PRT-
  • •Provide informed consent
  • •Willing to participate in the ophthalmological examinations

排除标准

  • •Patients with severe ocular or general disorders that would prevent them from completed the visit.
  • •Patients not being able to understand and give informed consent.

研究组 & 干预措施

Post-presbyopia correction with unilaterally implanted microlens

Presbyopic patients who have undergone implantation of the CorVision microlens according to study protocol CMG-PRT-002.

结局指标

主要结局

Uncorrected Near Visual Acuity of 0.3 logMAR or better

时间窗: At least 4 years after the implantation

More than 65% of the eyes should have an Uncorrected Near Visual Acuity (UNVA) of 0.3 logMAR or better at 4 years postoperatively.

Implant removal

时间窗: At least 4 years after the implantation

The incidence of implant rejection leading to implant removal should occur in no more than 3% of implanted eyes.

次要结局

  • Clinically significant corneal haze occurrence(At least 4 years after the implantation)

研究者

发起方
Gemini Eye Clinic
申办方类型
Industry
责任方
Principal Investigator
主要研究者

Katerina Klimesova

Gemini Eye Clinic

Gemini Eye Clinic

研究点 (1)

Loading locations...

相似试验